Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

Published: 03/03/2025

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

tags

Latest News

NEWS 05.30.2026

Putin Funnels Billions Into Longevity Research as Russia Pursues Organ Printing and Anti-Aging Technologies – btimesonline.com

NEWS 05.30.2026

Regentis Biomaterials Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones – citybuzz –

NEWS 05.30.2026

BioRestorative Therapies Extends Executive Leadership Employment Agreements – TipRanks

NEWS 05.30.2026

29-Year-Old Leukemia Patient’s Viral Plea Is Exposing A Healthcare Crisis No One Talks About – BuzzFeed